Shelter Mutual Insurance Co trimmed its position in shares of CME Group Inc (NASDAQ:CME) by 8.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 55,390 shares of the financial services provider’s stock after selling 5,310 shares during the quarter. CME Group accounts for approximately 3.1% of Shelter Mutual Insurance Co’s portfolio, making the stock its 9th largest holding. Shelter Mutual Insurance Co’s holdings in CME Group were worth $10,752,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Truvestments Capital LLC purchased a new position in CME Group during the 1st quarter worth $32,000. Close Asset Management Ltd purchased a new position in CME Group during the 1st quarter worth $34,000. Advantage Investment Management LLC boosted its holdings in CME Group by 119.0% during the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock worth $36,000 after acquiring an additional 100 shares during the last quarter. Westside Investment Management Inc. purchased a new position in CME Group during the 2nd quarter worth $38,000. Finally, Permanens Capital L.P. purchased a new position in CME Group during the 1st quarter worth $41,000. 84.44% of the stock is currently owned by hedge funds and other institutional investors.
CME has been the topic of a number of analyst reports. Rosenblatt Securities downgraded shares of CME Group from a “neutral” rating to a “sell” rating in a report on Thursday, April 18th. Deutsche Bank boosted their price target on shares of CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a report on Friday, August 9th. Citigroup set a $202.00 price target on shares of CME Group and gave the stock a “buy” rating in a report on Thursday, May 2nd. BidaskClub raised shares of CME Group from a “hold” rating to a “buy” rating in a report on Friday, August 9th. Finally, Barclays boosted their price target on shares of CME Group from $191.00 to $197.00 and gave the stock an “overweight” rating in a report on Thursday, May 23rd. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and eight have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $194.00.
In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the sale, the chief executive officer now directly owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Kathleen M. Cronin sold 4,960 shares of the company’s stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $186.69, for a total transaction of $925,982.40. Following the sale, the insider now directly owns 49,337 shares in the company, valued at $9,210,724.53. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 82,363 shares of company stock worth $16,429,225. Insiders own 1.20% of the company’s stock.
NASDAQ CME traded up $3.69 during trading on Thursday, hitting $212.03. 493,475 shares of the company’s stock traded hands, compared to its average volume of 1,342,918. The stock has a market capitalization of $75.78 billion, a PE ratio of 31.09, a price-to-earnings-growth ratio of 4.73 and a beta of 0.23. CME Group Inc has a 12-month low of $161.05 and a 12-month high of $216.73. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. The business’s 50 day simple moving average is $203.69.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.75 by $0.01. The business had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The company’s revenue was up 20.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.74 earnings per share. On average, research analysts expect that CME Group Inc will post 6.68 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.41%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 43.99%.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.